Yuji Koriyama

Synthesis and structure–activity relationships of novel IKK-β inhibitors. Part 3: Orally active anti-inflammatory agents

Toshiki Murata, Mitsuyuki Shimada, Sachiko Sakakibara et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 118 citations · Full text

Inflammation, Medicinal Chemistry, Anti-inflammatory +11

Discovery of Atabecestat (JNJ-54861911): A Thiazine-Based β-Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor Advanced to the Phase 2b/3 EARLY Clinical Trial

Yuji Koriyama, Akihiro Hori, Hisanori Ito et al. · Journal of Medicinal Chemistry · 2021 · 48 citations · Full text

Reversal of diastereofacial selectivity in the nucleophilic addition reaction to chiral N-sulfinimine and application to the synthesis of indrizidine 223AB

Yuji Koriyama, Akihiro Nozawa, Ryuuichirou Hayakawa et al. · Tetrahedron · 2002 · 42 citations

Asymmetric Catalysis, Engineering, Indrizidine 223Ab +8

2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 3: Synthesis and activity of isosteric analogs

Hiroyuki Kai, Yasuhide Morioka, Yuji Koriyama et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 36 citations · Full text

Cannabis Use, Medicinal Chemistry, Functional Selectivity +10